10-08-2022 | Hepatocellular Carcinoma | Letter to the Editor
The era of prostate-specific membrane antigen (PSMA)–based theranostics for hepatocellular carcinoma is upcoming: are we ready for it?
Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 12/2022
Login to get access